Publication

Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV

Explore population PK modeling of dolutegravir in plasma and cerebrospinal fluid to characterize CNS penetration…

CertaraOctober 5, 2026

Publication

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

Explore a simultaneous population PK/PD model characterizing the dynamic relationships between belantamab mafodotin, sBCMA, and…

CertaraOctober 5, 2026

Webinar

How Do You Know You Have the Right Dose? Using Exposure-Response Evidence to Justify and Defend Dose Decisions

Danielle PillsburyOctober 1, 2026

Webinar

Enable AI to Access your PK Data: What’s New in Integral 7.1

CertaraSeptember 24, 2026

Publication

Modeling effective doses of therapeutic antibodies targeting clustered surface receptors

Discover how semi-mechanistic PK/receptor-occupancy modeling reveals that lower, subcutaneous doses, not maximum tolerated doses, optimize…

Danielle PillsburySeptember 23, 2026

White Paper

Model-Informed Strategies for ADC Development

Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen…

Danielle PillsburySeptember 22, 2026

Publication

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

A semi-mechanistic population PK model characterizes sorfequiline and its active M3 metabolite to support DDI…

CertaraSeptember 18, 2026

Poster

Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy

Pharmacometric modeling of givinostat in pediatric DMD supported a simplified 4-band weight-based dosing regimen without…

CertaraSeptember 14, 2026

Blog

Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions

Simple allometric scaling stops at clearance and volume. See how Dedrick plots and the Wajima…

Danielle PillsburySeptember 11, 2026

On-Demand Webinar

From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud

Go from raw PK data to a submission-ready deliverable in a day. See AI-assisted non-compartmental…

Arjen BosSeptember 3, 2026

Modeling and Simulation – PK/PD

Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

How Do You Know You Have the Right Dose? Using Exposure-Response Evidence to Justify and Defend Dose Decisions

Enable AI to Access your PK Data: What’s New in Integral 7.1

Modeling effective doses of therapeutic antibodies targeting clustered surface receptors

Model-Informed Strategies for ADC Development

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy

Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions

From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud

Newsletter sign up

Quick links

Solutions

Contact